Table 1.
Demographic, clinical, biochemical characteristics, echocardiographic measurement, cardiac magnetic resonance (CMR) T2*, time-domain and frequency-domain HRV parameters of non-transfusion dependent thalassemia (NTDT) patients (n = 99).
Table 2.
The correlations between HRV parameters and other clinical parameters in non-transfusion dependent thalassemia (NTDT) patients.
Fig 1.
Receiver operating characteristic (ROC) curve of the HRV for the prediction of myocardial iron deposition determined by CMR T2*.